126 - 150 of 241 Items

Clinical vignette2023, feb 21

Liraglutide therapy in an adolescent with Prader‑Willi syndrome and concomitant diabetes mellitus

Ming Li, Nan Li, Zhufang Tian, Xiang Wang

Vol 74, No 2 (2023)

Clinical vignette

Pubmed: 36916545
Endokrynol Pol 2023;74(2):219-220.
Original paper2023, mar 10

MicroRNA-196a-5p targeting LRP1B modulates phenotype of thyroid carcinoma cells

Yaojie Hu, Chunying Zhang, Qing Chang, Jinghai Du, Haodong Lu, Xin Guo, Wang Chang, Shiguang Liu, Chunyou Chen

Vol 74, No 2 (2023)

Original paper

Pubmed: 36916542
Endokrynol Pol 2023;74(2):144-152.
Clinical vignette2023, mar 24

Difficulties in the diagnosis and treatment of ruptured pheochromocytoma

Joanna Kokoszka, Ewelina Rzepka, Magdalena Ulatowska-Białas, Piotr Richter, Alicja Hubalewska-Dydejczyk

Vol 74, No 2 (2023)

Clinical vignette

Pubmed: 37039495
Endokrynol Pol 2023;74(2):211-212.
Guidelines / Expert consensus2023, apr 28

Zalecenia postępowania diagnostycznego i leczniczego w osteoporozie w Polsce. Aktualizacja 2022

Piotr Głuszko, Ewa Sewerynek, Waldemar Misiorowski, Jerzy Konstantynowicz, Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Mirosław Jabłoński, Edward Franek, Tomasz Kostka, Maciej Jaworski, Elżbieta Karczmarewicz, Ewa Kalinka, Krystyna Księżopolska-Orłowska, Andrzej Więcek, Roman S. Lorenc

Vol 74, Supp. A (2023)

Guidelines / Expert consensus

DOI: 10.5603/ep.94310
Original paper2023, jun 21

Osteoporosis treatment with denosumab in routine clinical practice in Poland

Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Ewa Wielosz, Maria Rell-Bakalarska, Krzysztof Duma, Katarzyna Paradowska-Kowal, Ewa Sewerynek

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695033
Endokrynol Pol 2023;74(3):243-253.
Original paper2023, may 2

The association between complement C1q tumour necrosis factor-related protein-1 (CTRP-1) level and metabolic syndrome

Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155309
Endokrynol Pol 2023;74(3):271-276.
Original paper2023, jun 12

Demographics, practice patterns, job satisfaction, and career plans of endocrinologists in Poland

Wojciech S. Zgliczyński, Adam Skowron

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335066
Endokrynol Pol 2023;74(3):331-339.
Original paper2023, may 15

Irisin attenuates pyroptosis in high glucose-induced pancreatic beta cells via the miR-133a-3p/FOXO1 axis

Anjun Tan, Tianrong Li, Jingjing Yang, Jinwen Yu, Hewen Chen

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335063
Endokrynol Pol 2023;74(3):277-284.
Original paper2023, jun 12

The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome

Anna Świąder-Leśniak, Dorota Jurkiewicz, Honorata Kołodziejczyk, Agata Kozłowska, Alicja Korpysz, Mieczysław Szalecki, Krystyna Chrzanowska

Vol 74, No 3 (2023)

Original paper

Pubmed: 37335065
Endokrynol Pol 2023;74(3):285-293.
Original paper2023, may 29
Original paper2023, jun 21

Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma

Bingqing Xu, Ruohuang Wang, Jisheng Zhang, Lin Wang, Xin Cui, Fangyu Chai, Xiaoyun Du, Yan Jiang

Vol 74, No 3 (2023)

Original paper

Pubmed: 37695034
Endokrynol Pol 2023;74(3):315-330.
Original paper2023, may 8

MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS)

Jiali Lu, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Yongju Ye, Yuefang Ren

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155307
Endokrynol Pol 2023;74(3):305-314.
Original paper2023, may 2

The impact of subclinical hypothyroidism on growth and development in infants and young children aged 0 to 5 years

Xueqin Yan, Guomei Jiang, Chunhui Yang, Yuming Chen, Jie Zeng, Lianhong Huang, Xia Chen, Jialuo Liao

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155310
Endokrynol Pol 2023;74(3):254-259.
Review paper2023, nov 7

Obesity in perimenopause — current treatment options based on pathogenetic factors

Dominik Porada, Jakub Gołacki, Beata Matyjaszek-Matuszek

Vol 74, No 6 (2023)

Review paper

Pubmed: 37994584
Endokrynol Pol 2023;74(6).
Original paper2023, may 4

Leukocyte transcriptome of Cushing’s disease are associated with nerve impairment and psychiatric disorders

Kunyu He, Tao Zhou, Fuyu Wang, Fangye Li, Yanyang Zhang, Xinguang Yu

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155308
Endokrynol Pol 2023;74(3):294-304.
Clinical vignette2023, jun 12

COVID-19 infection in a patient with Cushing’s disease on osilodrostat treatment

Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37335068
Endokrynol Pol 2023;74(3):342-343.
Clinical vignette2023, jun 21

Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing’s disease

Bartłomiej Borawski, Agnieszka Wojciechowska-Luźniak, Grzegorz Zieliński, Przemysław Witek

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37695035
Endokrynol Pol 2023;74(3):346-347.
Clinical vignette2023, may 8

Ectopic parathyroid adenoma in a patient with multiple endocrine tumours

Inês Lemos Damásio, Inês Patrocínio Carvalho, Sara de Miranda Lemos Donato Bento, Valeriano Alberto Pais Horta Leite

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155305
Endokrynol Pol 2023;74(3):344-345.
Clinical vignette2023, may 8

Adverse outcome of T3-predominant maternal Grave’s disease during pregnancy in the mother and the offspring

Aleksandra Mikołajczak, Renata Bokiniec, Agnieszka Sienicka, Agata Pisula, Ewa Romejko-Wolniewicz

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155306
Endokrynol Pol 2023;74(3):340-341.
Review paper2023, aug 17

The antifracture efficacy of vitamin D in adults — are we assessing it reliably? A systematic review

Jerzy Przedlacki, Urszula Ołdakowska-Jedynak

Vol 74, No 5 (2023)

Review paper

Pubmed: 37779375
Endokrynol Pol 2023;74(5):499-510.
Review paper2023, jun 30

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek-Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Gregory Y. H. Lip

Vol 74, No 4 (2023)

Review paper

Pubmed: 37431873
Endokrynol Pol 2023;74(4):349-362.
Original paper2022, jul 18

Association of antithyroid peroxidase antibodies with cardiac function in euthyroid women with type 1 diabetes mellitus — assessment with two-dimensional speckle‑tracking echocardiography

Magdalena Maria Łukawska-Tatarczuk, Agnieszka Pawlak, Jakub Zieliński, Edward Franek, Leszek Czupryniak, Beata Mrozikiewicz-Rakowska

Vol 73, No 5 (2022)

Original paper

Pubmed: 35971937
Endokrynol Pol 2022;73(5):812-822.
Guidelines / Expert consensus2023, oct 23

Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology

Waldemar Misiorowski, Marek Dedecjus, Jerzy Konstantynowicz, Arkadiusz Zygmunt, Beata Kos-Kudła, Andrzej Lewiński, Marek Ruchała, Wojciech Zgliczyński

Vol 74, No 5 (2023)

Guidelines / Expert consensus

Pubmed: 37902011
Endokrynol Pol 2023;74(5):447-467.
Review paper2023, oct 27

Mitophagy in tumor: foe or friend?

Li Li, Fei Hu

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902014
Endokrynol Pol 2023;74(5):511-519.
Review paper2023, aug 17